0000000001137136

AUTHOR

Giardina Ar

showing 17 related works from this author

Disfunzione diastolica in pazienti affetti da artrite reumatoide:ruolo della terapia con anti-TNF

2006

researchProduct

Le Spondiloartriti.

2004

researchProduct

Efficacia e sicurezza del trattamento con inibitori del TNF in pazienti affetti da spondilite anchilosante: uno studio osservazionale a 2 anni.

2006

researchProduct

La determinazione degli anticorpi antipeptide, C citrullinato è utile nel discriminare pazienti con artrite reumatoide da quelli con poliartrite asso…

2005

researchProduct

Iniezione locale di infliximab nel trattamento della dattilite

2005

researchProduct

DIASTOLIC DYSFUNCTION IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH TNF BLOCKING AGENTS

2006

researchProduct

Efficacia e sicurezza di infliximab nelle spondiloartriti indifferenziate: follow-up a 2 anni

2005

researchProduct

Atherosclerosis in female patients with rheumatoid arthritis: a two years of follow up

2005

researchProduct

Disfunzione diastolica in pazienti affetti da artrite reumatoide: ruolo della terapia con anti-TNFα

2006

researchProduct

pentoxifylline inhibits vgamma9/vdelta2 t lymphocyte activation of patients with active behçet's disease

2007

The aim ofthis study is to evaluate the in vitro effect ofpentoxifylline (PTX) on T Vy9No21ymphocyte function in Beheet's disease (DO). We investigated the effect of PTX on Vy9No2 T cell expansion and expression of TNFRII receptor and perforin content before and after PTX addition by means of FACS analysis lymphocyte cultures from patients with active and inactive DO and healthy subjects. The addition of PTX at a concentration of 1 mg/ml determined a significant inhibition of cell expansion, a down regulation of TNF receptor expression and inhibited the PMA-induced degranulation of perforin. Taken together these data indicate that PTX is capable of interfering with Vy9No2 T cell function in…

pentoxifyllineBehcet s diseaseVy9/Vc>2 T lymphocyteBehcet s disease Vy9/Vc>2 T lymphocytes perforin pentoxifyllineperforin
researchProduct

Profilo citochinico ed espressione di STATS e SOCS nell’intestino di pazienti affetti da spondilite anchilosante

2006

researchProduct

THE LEVEL OF SOLUBLE GRANZYME A IS ELEVATED IN THE PLASMA AND IN THE Vgamma9/Vdelta2 T CELL CULTURE SUPERNATANTS OF PATIENTS WITH ACTIVE BEHCET'S DIS…

2004

Gramzyme A (GrA) is a serine proteinase with trypsin-like activity that is released extracellularly during the degranulation of cytotoxic cells. Among the cytotoxic cells, gamma/delta T cells participate in the early phases of the immune response and are known to express perforin and granzymes constitutively in agreement with their cytolytic pontential.GrA activity was detected using the synthetic substrate N-alpha-benzyloxycarbonyl-L-lysine thiobenzyl ester in the plasma and supernatants of peripheral blood mononuclear cell cultured in the presence of Dimethylallyl pyrophosphate to obtain Vgamma9/Vdelta2 T cell expansion.Significantly high levels of GrA were found in the serum and supernat…

AdultMaleAdolescentDose-Response Relationship DrugBehcet SyndromeT-LymphocytesSerine EndopeptidasesReceptors Antigen T-Cell gamma-deltaMiddle AgedFlow CytometryGranzymesCulture Media ConditionedHumansFemaleCells CulturedAged
researchProduct

Fattori prognostici e predittivi della early arthritis

2006

researchProduct

The level of solubile granzyme A is elevated in the plasma and in the Vγ9/Vδ2 T cell culture supernatants of patients with active Behçet's disease.

2004

researchProduct

Fattori prognostici e predittivi della early arthritis (EA)

2006

researchProduct

Atherosclerosis in female patients with rheumatoid arthritis; a two years follow-up

2005

researchProduct

Impatto del trattamento precoce con infliximab + methotrexate (MTX) ed alte dosi di prednisone (PDN) vs infliximab (IFX)+methotrexate (MTX) e basse d…

2006

researchProduct